Tilray Brands, Inc. (TLRY.TO)
CAD 0.62
(-6.06%)
CAD 0.62
(-6.06%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 158.97 Million USD | -58.55% |
| 2022 | 383.49 Million USD | 84.47% |
| 2021 | 207.89 Million USD | -53.82% |
| 2020 | 450.19 Million USD | 874.22% |
| 2019 | -58.14 Million USD | -26.48% |
| 2018 | -45.97 Million USD | -106.92% |
| 2017 | -22.21 Million USD | 35.6% |
| 2016 | -34.5 Million USD | -173.19% |
| 2015 | -12.62 Million USD | -122.58% |
| 2014 | -5.67 Million USD | -47751.71% |
| 2013 | -11.85 Thousand CAD | -101.95% |
| 2012 | 609.62 Thousand USD | 2657.67% |
| 2011 | -23.83 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 116.93 Million USD | 0.44% |
| 2023 FY | 158.97 Million USD | -58.55% |
| 2023 Q4 | 158.97 Million USD | -52.6% |
| 2023 Q3 | 335.36 Million USD | -13.12% |
| 2023 Q2 | 386 Million USD | 0.21% |
| 2023 Q1 | 385.19 Million USD | 0.44% |
| 2022 Q4 | 383.49 Million USD | -12.59% |
| 2022 FY | 383.49 Million USD | 84.47% |
| 2022 Q1 | 167.17 Million USD | -19.59% |
| 2022 Q2 | 418.69 Million USD | 150.45% |
| 2022 Q3 | 438.73 Million USD | 4.79% |
| 2021 Q2 | 467.98 Million USD | -5.92% |
| 2021 Q1 | 497.43 Million USD | 10.49% |
| 2021 Q4 | 207.89 Million USD | -54.17% |
| 2021 Q3 | 453.65 Million USD | -3.06% |
| 2021 FY | 207.89 Million USD | -53.82% |
| 2020 Q3 | 519.16 Million USD | 87.5% |
| 2020 Q2 | 276.89 Million USD | 1368.94% |
| 2020 Q1 | 18.84 Million USD | 132.42% |
| 2020 FY | 450.19 Million USD | 874.22% |
| 2020 Q4 | 450.19 Million USD | -13.29% |
| 2019 FY | -58.14 Million USD | -26.48% |
| 2019 Q1 | 18.55 Million USD | 140.36% |
| 2019 Q3 | -22.38 Million USD | -481.95% |
| 2019 Q2 | 5.85 Million USD | -68.42% |
| 2019 Q4 | -58.14 Million USD | -159.81% |
| 2018 FY | -45.97 Million USD | -106.92% |
| 2018 Q4 | -45.97 Million USD | -100.66% |
| 2018 Q3 | -22.91 Million USD | 68.61% |
| 2018 Q2 | -72.99 Million USD | 56.34% |
| 2018 Q1 | -167.18 Million USD | -652.48% |
| 2017 Q3 | -63.23 Million USD | 2.56% |
| 2017 Q4 | -22.21 Million USD | 64.86% |
| 2017 FY | -22.21 Million USD | 35.6% |
| 2017 Q1 | -4.18 Million USD | 87.88% |
| 2017 Q2 | -64.89 Million USD | -1451.6% |
| 2016 FY | -34.5 Million USD | -173.19% |
| 2016 Q4 | -34.5 Million USD | 39.77% |
| 2016 Q3 | -57.28 Million USD | 15.49% |
| 2016 Q1 | -34.92 Million USD | -176.56% |
| 2016 Q2 | -67.78 Million USD | -94.05% |
| 2015 FY | -12.62 Million USD | -122.58% |
| 2015 Q4 | -12.62 Million USD | -41.99% |
| 2015 Q3 | -8.89 Million USD | -261.96% |
| 2015 Q2 | -2.45 Million USD | 35.16% |
| 2015 Q1 | -3.79 Million USD | 33.2% |
| 2014 FY | -5.67 Million USD | -47751.71% |
| 2014 Q4 | -5.67 Million USD | 23.19% |
| 2014 Q3 | -7.38 Million USD | -6556.29% |
| 2014 Q2 | -110.97 Thousand USD | -835.88% |
| 2014 Q1 | -11.85 Thousand USD | -76.86% |
| 2013 Q2 | -1920.54 USD | 80.3% |
| 2013 Q1 | -9747.68 USD | -601.59% |
| 2013 FY | -11.85 Thousand CAD | -101.95% |
| 2013 Q4 | -6704.57 USD | 40.9% |
| 2013 Q3 | -11.34 Thousand USD | -490.72% |
| 2012 FY | 609.62 Thousand USD | 2657.67% |
| 2012 Q1 | -23.83 Thousand USD | 41.82% |
| 2012 Q4 | -1389.37 USD | 90.89% |
| 2012 Q3 | -15.24 Thousand USD | 30.29% |
| 2012 Q2 | -21.87 Thousand USD | 8.23% |
| 2011 FY | -23.83 Thousand USD | 0.0% |
| 2011 Q2 | -64.46 Thousand USD | 0.0% |
| 2011 Q4 | -40.96 Thousand USD | 11.68% |
| 2011 Q3 | -46.38 Thousand USD | 28.05% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | -8.64 Million CAD | 1938.309% |
| Avicanna Inc. | 1.32 Million CAD | -11887.417% |
| Avant Brands Inc. | 17.93 Million CAD | -786.654% |
| Cardiol Therapeutics Inc. | -34.77 Million CAD | 557.182% |
| Crescita Therapeutics Inc. | -8.13 Million CAD | 2055.196% |
| Knight Therapeutics Inc. | 10.33 Million CAD | -1438.984% |
| MediPharm Labs Corp. | -15.68 Million CAD | 1113.496% |
| OrganiGram Holdings Inc. | -33.7 Million CAD | 571.616% |
| Canopy Growth Corporation | 512.87 Million CAD | 69.003% |
| Willow Biosciences Inc. | -989 Thousand CAD | 16174.52% |
| Auxly Cannabis Group Inc. | 142.88 Million CAD | -11.266% |